FDA Inspection
Ursapharm Arzneimittel GmbHUrsapharm Arzneimittel GmbH – FDA Inspection, Sep 13, 2013
Record Details
This FDA Inspection record concerns Ursapharm Arzneimittel GmbH, with an inspection on September 13, 2013, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Ursapharm Arzneimittel GmbH
- Inspection Date
- September 13, 2013
- Product Type
- Drugs
View Company Profile
ID · 81afa5c0-97a3-47d8-bbb4-1f1cbbc44064
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 854124
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
1- 21 CFR 211.113(b)Procedures for sterile drug products
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Ursapharm Arzneimittel GmbH
2| Date | Classification | Office | Project area |
|---|---|---|---|
| October 31, 2024 | Not classified | Office of Inspections and Investigations | |
| September 25, 2015 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Ursapharm Arzneimittel GmbH
- FDA Inspection 1259338 - 2024-10-31
- FDA Inspection 945426 - 2015-09-25
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.